These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 13494099)

  • 21. [Notes on a focus of kala-azar in the southeastern part of the state of Goiás].
    Coelho MV; Cunha AS; Falcão AR
    Rev Bras Malariol Doencas Trop; 1965; 17(2):143-8. PubMed ID: 5887877
    [No Abstract]   [Full Text] [Related]  

  • 22. Peoples participation in control of kala-Azar.
    Yadava DK
    Indian J Pathol Microbiol; 1999 Oct; 42(4):509-10. PubMed ID: 11127391
    [No Abstract]   [Full Text] [Related]  

  • 23. Kala-azar in Sidamo, South Ethiopia.
    Lindtjorn B
    Ethiop Med J; 1980 Jul; 18(3):99-100. PubMed ID: 7439151
    [No Abstract]   [Full Text] [Related]  

  • 24. Kala-azar elimination programme in India.
    Dhillon GP; Sharma SN; Nair B
    J Indian Med Assoc; 2008 Oct; 106(10):664, 666-8. PubMed ID: 19552101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal.
    Rijal S; Boelaert M; Regmi S; Karki BM; Jacquet D; Singh R; Chance ML; Chappuis F; Hommel M; Desjeux P; Van der Stuyft P; Le Ray D; Koirala S
    Trop Med Int Health; 2004 Jun; 9(6):724-9. PubMed ID: 15189464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Note on Kala-azar control programme in India.
    Sharma SN
    J Indian Med Assoc; 2008 Oct; 106(10):669-70, 672. PubMed ID: 19552102
    [No Abstract]   [Full Text] [Related]  

  • 27. A case report of visceral leishmaniasis in the Tharaka District, Kenya.
    Pelizzi M; Verna M; Vanelli M
    Acta Biomed; 2006 Aug; 77(2):103-5. PubMed ID: 17172190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Points to consider in controlling kala azar in Kenya.
    Mbati PA
    East Afr Med J; 1995 Nov; 72(11):751. PubMed ID: 8904073
    [No Abstract]   [Full Text] [Related]  

  • 29. [Kalaazar in Minas Gerais. Clinical and immuno-serological survey in the Hospital das Clinicas and in the Santa Casa de Misericordia de Belo Horizonte, to identify cases of kala-azar].
    NEVES J; MAYRINK W; MOURAO OG; CARDOSO JP
    Hospital (Rio J); 1961 Jun; 59():1165-77. PubMed ID: 13728601
    [No Abstract]   [Full Text] [Related]  

  • 30. [Kala-azar].
    HERTWIG F; OBERDOERSTER F
    Z Tropenmed Parasitol; 1960 Dec; 11():401-9. PubMed ID: 13713816
    [No Abstract]   [Full Text] [Related]  

  • 31. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
    Koirala S; Karki P; Das ML; Parija SC; Karki BM
    Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two cases of Kala-azar in Haryana with no evidence of local transmission.
    Kaushal K; Veena M
    J Commun Dis; 2008 Mar; 40(1):87-8. PubMed ID: 19127677
    [No Abstract]   [Full Text] [Related]  

  • 34. Availability of miltefosine for the treatment of kala-azar in India.
    Sundar S; Murray HW
    Bull World Health Organ; 2005 May; 83(5):394-5. PubMed ID: 15976883
    [No Abstract]   [Full Text] [Related]  

  • 35. A report on the indoor residual spraying (IRS) in the control of Phlebotomus argentipes, the vector of visceral leishmaniasis in Bihar (India): an initiative towards total elimination targeting 2015 (Series-1).
    Kumar V; Kesari S; Dinesh DS; Tiwari AK; Kumar AJ; Kumar R; Singh VP; Das P
    J Vector Borne Dis; 2009 Sep; 46(3):225-9. PubMed ID: 19724087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unusual presentation of post-kala-azar dermal leishmaniasis.
    Ramesh V; Kumar J; Salotra P
    Trop Doct; 2007 Jul; 37(3):172-3. PubMed ID: 17716510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil.
    Lima Verde FA; Lima Verde FA; Lima Verde IA; Silva Junior GB; Daher EF; Lima Verde EM
    J Nephrol; 2007; 20(4):430-6. PubMed ID: 17879209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral leishmaniasis (kala-azar) and pregnancy.
    Figueiró-Filho EA; Duarte G; El-Beitune P; Quintana SM; Maia TL
    Infect Dis Obstet Gynecol; 2004; 12(1):31-40. PubMed ID: 15460194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.